<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02244814</url>
  </required_header>
  <id_info>
    <org_study_id>14-1358</org_study_id>
    <nct_id>NCT02244814</nct_id>
  </id_info>
  <brief_title>Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring</brief_title>
  <acronym>CHOICE</acronym>
  <official_title>Randomized Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rapidly rising risk of gestational diabetes pregnant women demands that an effective diet&#xD;
      strategy be developed due to the high risk of fetal overgrowth, which places the newborn at&#xD;
      increased risk for childhood obesity and metabolic syndrome. The aims of this randomized&#xD;
      clinical trial are to compare the effects of an 8-wk isocaloric higher complex&#xD;
      carbohydrate/lower fat diet vs. a conventional lower carbohydrate (higher fat) diet on&#xD;
      glycemic and lipid profiles, maternal insulin resistance, placenta nutrient transporters, the&#xD;
      maternal microbiome, neonatal intrahepatic fat, and neonatal total adiposity (primary&#xD;
      outcome). The investigators will then follow the infants for 1-yr and measure maternal breast&#xD;
      milk and infant microbiome composition to observe if they impact net fat mass gain&#xD;
      differently in infants exposed to one diet vs. the other. Identifying a diet for gestational&#xD;
      diabetes mellitus women that can effectively alter maternal/fetal metabolism is critical to&#xD;
      reducing short- and long-term metabolic risk in this growing cohort of mothers and infants&#xD;
      and has the potential to be applicable to overweight/obese pregnant women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rapidly rising incidence of gestational diabetes mellitus in overweight/obese pregnant&#xD;
      women demands that an effective diet strategy be developed due to the high risk of fetal&#xD;
      overgrowth, which places the newborn at increased risk for childhood obesity and metabolic&#xD;
      syndrome. However, the lack of adequate controlled randomized clinical trials for treatment&#xD;
      of gestational diabetes with diet has resulted in consensus panels abandoning any specific&#xD;
      diet recommendation. If effective, diet therapy has the potential to avoid the high costs of&#xD;
      medical treatment and intensified fetal monitoring for this growing population. Although a&#xD;
      low carbohydrate diet has historically been advocated to decrease glucose excursions after&#xD;
      meals, carbohydrate has typically been replaced by higher fat which has been shown in animal&#xD;
      and non-human primate data to promote insulin resistance, glucose intolerance, and liver fat&#xD;
      deposition in the offspring. In fact, recent human data suggest that high maternal&#xD;
      triglycerides and free fatty acids, variables sensitive to dietary manipulation, may be at&#xD;
      least as important as glucose in contributing to excess fetal growth and infant adiposity.&#xD;
      Preliminary data based on an R21, show that compared to a conventional lower-carbohydrate&#xD;
      (higher in fat) diet, providing a higher complex carbohydrate (lower fat) diet effectively&#xD;
      blunts postprandial glucose and improves fasting glucose and insulin after 6-7 weeks, with&#xD;
      less adiposity in the newborn. The investigators global hypothesis is that compared to 8&#xD;
      weeks of a low-carbohydrate/higher fat diet, a higher complex carbohydrate/lower fat diet&#xD;
      will blunt maternal post-prandial free fatty acids and improve insulin resistance. Improved&#xD;
      insulin sensitivity will reduce fetal over-nutrition by decreasing substrate availability and&#xD;
      down-regulating placental nutrient transporters, thereby reducing neonatal adiposity (primary&#xD;
      outcome).This proposal builds on the investigators R21 study, which is the first randomized&#xD;
      clinical trial to provide all meals from the time of gestational diabetes diagnosis&#xD;
      throughout the remainder of pregnancy. The aims of this randomized trial are to compare the&#xD;
      effects of an 8-wk isocaloric higher complex carbohydrate/lower fat diet (60%&#xD;
      carbohydrate/25% fat) vs. a conventional low-carbohydrate (higher fat)(40% carbohydrate/45%&#xD;
      fat) diet on maternal insulin resistance, placental nutrient transporters, and neonatal fat&#xD;
      development. Innovative approaches by the investigators skilled multidisciplinary team&#xD;
      include: maternal insulin resistance systemically (oral glucose tolerance Index) and locally&#xD;
      (adipose tissue lipolysis); intestinal microbiome (transferred to the newborn); and neonatal&#xD;
      intrahepatic fat (magnetic resonance spectroscopy). Persistence of neonatal adiposity is&#xD;
      relevant to understanding obesity risk in these infants. As the investigators pilot data&#xD;
      suggest infant microbiome and breast milk composition impact fat accrual after birth, the&#xD;
      investigators will follow the infants through 1-yr of life accounting for these variables.&#xD;
      Identifying a diet for gestational diabetes that can effectively alter maternal/fetal&#xD;
      metabolism in late pregnancy when fetal growth accelerates is critical to reducing short- and&#xD;
      long-term metabolic risk in this growing cohort of mothers and infants. The study results&#xD;
      could lead to a paradigm shift for diet therapy in gestational diabetes, with potential&#xD;
      widespread application to pregnancies affected by obesity alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">November 2020</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal adiposity</measure>
    <time_frame>5-7 days after birth</time_frame>
    <description>Air-displacement plethysmography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal Insulin Resistance</measure>
    <time_frame>36 wks gestation</time_frame>
    <description>Between-diet difference in post-prandial free fatty acid area-under-the-curve as a surrogate for insulin resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placental fatty acid transporter protein-2 expression</measure>
    <time_frame>Delivery</time_frame>
    <description>Between diet-difference in protein expression of placental fatty acid transporter protein-2.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Oral glucose tolerance test</measure>
    <time_frame>Baseline, 36 wks</time_frame>
    <description>75g oral glucose tolerance test; calculated Index to assess diet-induced differences in maternal insulin resistance.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adipose Tissue Lipolysis</measure>
    <time_frame>Baseline, 36 wks</time_frame>
    <description>Diet-induced difference in adipose tissue lipolysis.</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant Adiposity</measure>
    <time_frame>Birth-12 mos</time_frame>
    <description>Infant adiposity (air displacement plethysmography, anthropometry) from delivery - 1 year (dual x-ray absorptiometry)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Gestational Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Choosing Healthy Options in Carbohydrate Energy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60% carbohydrate/25% fat/15% protein diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Carbohydrate/Conventional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40% carbohydrate/45% fat/15% protein</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Carbohydrate/Conventional</intervention_name>
    <description>Lower-carbohydrate/conventional diet (usual care)</description>
    <arm_group_label>Choosing Healthy Options in Carbohydrate Energy</arm_group_label>
    <arm_group_label>Low Carbohydrate/Conventional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Choosing Healthy Options in Carbohydrate Energy</intervention_name>
    <description>Choosing Healthy Options in Carbohydrate Energy</description>
    <arm_group_label>Choosing Healthy Options in Carbohydrate Energy</arm_group_label>
    <arm_group_label>Low Carbohydrate/Conventional</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women will be between the ages of 20-36 yrs&#xD;
&#xD;
          -  BMI of 26-39 kg/m2 at the time of diagnosis&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  no oral hypoglycemic therapy before entering the study&#xD;
&#xD;
          -  diagnosed with Gestational diabetes according to the criteria established by the&#xD;
             American College of Obstetricians and Gynecologists, specifically, they will have 2&#xD;
             abnormal values on a 100-g 3 hr glucose tolerance test 205, 206: Fasting&gt;95 mg/dL but&#xD;
             &lt;105 mg/dL; 1hr&gt; 180 mg/dL; 2 hr&gt;155 mg/dL; 3 hr&gt;140 mg/dL.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  extreme hypertriglyceridemia&#xD;
&#xD;
          -  overt diabetes&#xD;
&#xD;
          -  suspected preexisting diabetes (A1C≥6.5%, Fasting glucose&gt;125 mg/dL, or random glucose&#xD;
             &gt;200/mg/dL)&#xD;
&#xD;
          -  women highly likely to fail diet by any of the following criteria will be excluded:1)&#xD;
             Fasting glucose &gt;105 mg/dL, due to the higher likelihood of failing diet and requiring&#xD;
             medical treatment 139; 2) Fasting triglyceride &gt; 400 mg/dL.&#xD;
&#xD;
          -  non-English speaking&#xD;
&#xD;
          -  Smokers (leading cause of low birth weight)&#xD;
&#xD;
          -  Risk factors for placental insufficiency (hypertension, renal disease, thrombophilias,&#xD;
             rheumatologic disease, preeclampsia, steroid use, history of pancreatitis, infectious&#xD;
             disease, or intrauterine growth restriction)&#xD;
&#xD;
          -  History of pancreatitis&#xD;
&#xD;
          -  History of pre-term labor&#xD;
&#xD;
          -  Taking beta blockers/glucocorticoids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teri L Hernandez, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado/Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hernandez TL, Van Pelt RE, Anderson MA, Daniels LJ, West NA, Donahoo WT, Friedman JE, Barbour LA. A higher-complex carbohydrate diet in gestational diabetes mellitus achieves glucose targets and lowers postprandial lipids: a randomized crossover study. Diabetes Care. 2014;37(5):1254-62. doi: 10.2337/dc13-2411. Epub 2014 Mar 4.</citation>
    <PMID>24595632</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 15, 2014</study_first_submitted>
  <study_first_submitted_qc>September 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2014</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glucose</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>dietary carbohydrate</keyword>
  <keyword>dietary fat</keyword>
  <keyword>adiposity</keyword>
  <keyword>Air displacement plethysmography</keyword>
  <keyword>Dual X-ray Absorptiometry</keyword>
  <keyword>continuous glucose monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

